| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Fampridine |
| Brand | Fampyra® |
| Indication | For the improvement of walking in adult patients with multiple sclerosis with walking disability (EDSS 4-7). |
| Assessment Process | |
| Rapid review commissioned | 01/09/2011 |
| Rapid review completed | 26/09/2011 |
| Rapid review outcome | Full Pharmaconomic Evaluation Recommended |
| Full pharmacoeconomic assessment commissioned by HSE | 23/05/2012 |
| NCPE assessment completed | 17/08/2012 |
| NCPE assessment outcome | Reimbursement not recommended |
As the manufacturer is unable to demonstrate the cost-effectiveness of fampridine we are unable to recommend reimbursement
